Nephrolithiasis/Ureterolithiasis/Nephrocalcinosis
The VA rates Nephrolithiasis/Ureterolithiasis/Nephrocalcinosis under Diagnostic Code 7508 at a single 30% level. The 30% maximum means additional ratings through secondary conditions or combined ratings are critical for higher compensation.
Rating schedule — DC 7508 at a glance
- Minimum rating
- 30%
- Maximum rating
- 30%
- Rating tiers
- 1
- CFR section
- § 4.115b
- Body system
- Genitourinary System
- Secondary conditions
- 0
Lowest schedular rating available
TDIU may raise effective compensation to 100%
30%
Part 4 rating schedule
None mapped
What are the VA rating criteria for Nephrolithiasis/Ureterolithiasis/Nephrocalcinosis?
| Rating | Criteria |
|---|---|
| 30% | Rate as hydronephrosis, except for recurrent stone formation requiring invasive or non-invasive procedures more than two times/year |
“Rate as hydronephrosis, except for recurrent stone formation requiring invasive or non-invasive procedures more than two times/year”
Common Questions About Nephrolithiasis/Ureterolithiasis/Nephrocalcinosis VA Ratings
What is the VA rating range for Nephrolithiasis/Ureterolithiasis/Nephrocalcinosis?
The VA rates Nephrolithiasis/Ureterolithiasis/Nephrocalcinosis under Diagnostic Code 7508 at 30%. The minimum 30% rating requires: Rate as hydronephrosis, except for recurrent stone formation requiring invasive or non-invasive procedures more than two times/year. The maximum 30% rating requires: Rate as hydronephrosis, except for recurrent stone formation requiring invasive or non-invasive procedures more than two times/year.
Which 38 CFR diagnostic code does the VA use for Nephrolithiasis/Ureterolithiasis/Nephrocalcinosis?
The VA rates Nephrolithiasis/Ureterolithiasis/Nephrocalcinosis under Diagnostic Code (DC) 7508, governed by 38 CFR 38 CFR § 4.115b. The diagnostic code establishes the specific rating tiers and severity criteria the VA examiner applies.
Can Nephrolithiasis/Ureterolithiasis/Nephrocalcinosis qualify for TDIU?
Nephrolithiasis/Ureterolithiasis/Nephrocalcinosis maxes at 30%, well below the single-disability TDIU threshold. However, combined with other service-connected disabilities, TDIU may be achievable under 38 CFR § 4.16. Focus on establishing secondary conditions to increase the combined rating.
What evidence supports a higher rating for Nephrolithiasis/Ureterolithiasis/Nephrocalcinosis?
The key evidence for Nephrolithiasis/Ureterolithiasis/Nephrocalcinosis is documentation of how the condition affects daily functioning. Treatment records showing worsening symptoms, functional limitations documented by your provider, and buddy statements describing observable impact on daily life all strengthen the claim. A nexus letter from a qualified medical professional linking the current severity to service is essential for contested claims.
What happens at the C&P exam for Nephrolithiasis/Ureterolithiasis/Nephrocalcinosis?
The C&P examiner uses a Genitourinary System DBQ and evaluates your condition against the DC 7508 rating criteria. The examiner documents symptom frequency, severity, and functional impact. Bring all treatment records and describe your worst days, not your best — the VA rates on the full clinical picture across time, not a snapshot of one good day.
Get a Personalized Rating Analysis
VeteranHQ evaluates your symptoms against the exact 38 CFR criteria, identifies secondary conditions, and shows what evidence you need to support a higher rating.
Discover Your Benefits